Overactive Bladder Global Clinical Trials Review, H1, 2020
Summary
The clinical trial report, “Overactive Bladder Global Clinical Trials Review, H1, 2020' provides an overview of Overactive Bladder Clinical trials scenario. This report provides top line data relating to the clinical trials on Overactive Bladder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Summary
The clinical trial report, “Overactive Bladder Global Clinical Trials Review, H1, 2020' provides an overview of Overactive Bladder Clinical trials scenario. This report provides top line data relating to the clinical trials on Overactive Bladder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
- Report Guidance
- Clinical Trials Report Coverage
- Clinical Trials by Region
- Clinical Trials and Average Enrollment by Country
- Top Five Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Five Countries Contributing to Clinical Trials in Middle East and Africa
- Top Five Countries Contributing to Clinical Trials in Central and South America
- Clinical Trials by G7 Countries: Proportion of Overactive Bladder to Genito Urinary System And Sex Hormones Clinical Trials
- Clinical Trials by Phase in G7 Countries
- Clinical Trials in G7 Countries by Trial Status
- Clinical Trials by E7 Countries: Proportion of Overactive Bladder to Genito Urinary System And Sex Hormones Clinical Trials
- Clinical Trials by Phase in E7 Countries
- Clinical Trials in E7 Countries by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Clinical Trials by End Point Status
- Subjects Recruited Over a Period of Time
- Clinical Trials by Sponsor Type
- Prominent Sponsors
- Top Companies Participating in Overactive Bladder Therapeutics Clinical Trials
- Prominent Drugs
- Latest Clinical Trials News on Overactive Bladder
- Oct 21, 2019: Urovant Sciences initiates part 2 of phase 3 COURAGE study of Vibegron for Overactive Bladder in Men with Benign Prostatic Hyperplasia
- Clinical Trial Profile Snapshots
- Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
- About the Author
- Contact Us
- Source
List of Tables
- Overactive Bladder Therapeutics, Global, Clinical Trials by Region, 2020*
- Overactive Bladder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
- Overactive Bladder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
- Overactive Bladder Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
- Overactive Bladder Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
- Overactive Bladder Therapeutics Clinical Trials, North America, Top Countries, 2020*
- Overactive Bladder Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020*
- Overactive Bladder Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020*
- Proportion of Overactive Bladder to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2020*
- Overactive Bladder Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
- Overactive Bladder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
- Proportion of Overactive Bladder to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2020*
- Overactive Bladder Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
- Overactive Bladder Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
- Overactive Bladder Therapeutics, Global, Clinical Trials by Phase, 2020*
- Overactive Bladder Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
- Overactive Bladder Therapeutics, Global, Clinical Trials by Trial Status, 2020*
- Overactive Bladder Therapeutics Clinical Trials, Global, by End Point Status, 2020*
- Overactive Bladder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
- Overactive Bladder Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
- Overactive Bladder Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
- Overactive Bladder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
- Overactive Bladder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
List of Figures
- Overactive Bladder Therapeutics, Global, Clinical Trials by Region (%), 2020*
- Overactive Bladder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
- Overactive Bladder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
- Overactive Bladder Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
- Overactive Bladder Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
- Overactive Bladder Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
- Overactive Bladder Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020*
- Overactive Bladder Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020*
- Proportion of Overactive Bladder to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2020*
- Overactive Bladder Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
- Overactive Bladder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
- Proportion of Overactive Bladder to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2020*
- Overactive Bladder Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
- Overactive Bladder Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
- Overactive Bladder Therapeutics, Global, Clinical Trials by Phase (%), 2020*
- Overactive Bladder Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
- Overactive Bladder Therapeutics, Global, Clinical Trials by Trial Status, 2020*
- Overactive Bladder Therapeutics Clinical Trials, Global, by End Point Status, 2020*
- Overactive Bladder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
- Overactive Bladder Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
- Overactive Bladder Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
- Overactive Bladder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
- Overactive Bladder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
- Methodology
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Astellas Pharma Inc
- Pfizer Inc
- Allergan Plc
- APOGEPHA Arzneimittel GmbH
- Helsinn Group
- Merck & Co Inc
- GlaxoSmithKline Plc
- KYORIN Holdings Inc
- Samsung Medical Center
- Novartis AG
